Impact of a pharmacist-led collaborative approach to care for treatment of COVID-19 in the outpatient setting
American Journal of Health-System Pharmacy · 2025
DOI: 10.1093/ajhp/zxae238 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift American Journal of Health-System Pharmacy, 2025. Verfasst von Jessica Potter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Legacy Medical Group, Portland, OR, USA. Hauptthemen laut MEDLINE: Pharmacists, Antiviral Agents, Ambulatory Care, COVID-19. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Purpose
The SARS-CoV-2 virus, causing COVID-19, remains a threat to patients and healthcare systems across the country. Oral antiviral therapy is available to reduce risk of patient hospitalization and death; however, limited access to medications, complex drug interactions, and the importance of timeliness in initiating therapy have proven to be challenging. This report aims to describe a pharmacist-driven telehealth service that provided safe and efficient access to antivirals for the treatment of COVID-19 and assess the population impacted. Summary This observational study was conducted from January 2022 to September 2023, during which time a COVID-19 pharmacist referral hub was utilized at Legacy Health. Patients documented to be positive for COVID-19 infection and who had a primary care provider within Legacy Health were included in the study. Demographics and descriptive data regarding antiviral prescribing for patients who were managed by an ambulatory care pharmacist were assessed. Patient demographics were statistically compared between groups to investigate antiviral access for marginalized populations. A total of 22,983 unique COVID-19 infections occurred during the study period, and ambulatory care pharmacists within Legacy Health managed 19.8% of all documented COVID-19 infections in our study population. The pharmacy team generated 3,820 antiviral prescriptions for treatment of COVID-19. The median time from symptom onset to antiviral prescription was 1 day.
Conclusion
This pharmacist-led telehealth service had a significant impact in expanding access to COVID-19 antiviral treatment, which is pivotal in broadening access to timely COVID-19 antiviral treatment for all vulnerable patient groups when resources are limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Legacy Medical Group, Portland, OR, USA.
- Legacy Medical Group, Portland, OR.
- Washington State Health Care Authority, Olympia, WA, USA.
Zitieren
APA
Potter, J., Chlasta, R., Miyama, K., Thompson-Moore, N., Blem, C., Wargo, R., Suzuki, M., & Grando Holman, Y. (2025). Impact of a pharmacist-led collaborative approach to care for treatment of COVID-19 in the outpatient setting. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxae238
Vancouver
Potter J, Chlasta R, Miyama K, Thompson-Moore N, Blem C, Wargo R, et al. Impact of a pharmacist-led collaborative approach to care for treatment of COVID-19 in the outpatient setting. American Journal of Health-System Pharmacy. 2025. doi:10.1093/ajhp/zxae238
BibTeX
@article{Potter2025,
author = {Potter, Jessica and Chlasta, Rachel and Miyama, Kelle and Thompson-Moore, Nathaniel and Blem, Chris and Wargo, Ryan and Suzuki, Marina and Grando Holman, Yvette},
title = {Impact of a pharmacist-led collaborative approach to care for treatment of COVID-19 in the outpatient setting},
journal = {American Journal of Health-System Pharmacy},
year = {2025},
doi = {10.1093/ajhp/zxae238}
}
EUVIMED